These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 11821035)

  • 1. Antipruritic activity of the kappa-opioid receptor agonist, TRK-820.
    Togashi Y; Umeuchi H; Okano K; Ando N; Yoshizawa Y; Honda T; Kawamura K; Endoh T; Utsumi J; Kamei J; Tanaka T; Nagase H
    Eur J Pharmacol; 2002 Jan; 435(2-3):259-64. PubMed ID: 11821035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of central mu-opioid system in the scratching behavior in mice, and the suppression of it by the activation of kappa-opioid system.
    Umeuchi H; Togashi Y; Honda T; Nakao K; Okano K; Tanaka T; Nagase H
    Eur J Pharmacol; 2003 Sep; 477(1):29-35. PubMed ID: 14512095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of acute herpetic pain-related responses by the kappa-opioid receptor agonist (-)-17-cyclopropylmethyl-3,14beta-dihydroxy-4,5alpha-epoxy-beta-[n-methyl-3-trans-3-(3-furyl) acrylamido] morphinan hydrochloride (TRK-820) in mice.
    Takasaki I; Suzuki T; Sasaki A; Nakao K; Hirakata M; Okano K; Tanaka T; Nagase H; Shiraki K; Nojima H; Kuraishi Y
    J Pharmacol Exp Ther; 2004 Apr; 309(1):36-41. PubMed ID: 14711930
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of TRK-820, a selective kappa opioid receptor agonist, on scratching behavior in an animal model of atopic dermatitis].
    Nakao K; Ikeda K; Kurokawa T; Togashi Y; Umeuchi H; Honda T; Okano K; Mochizuki H
    Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Apr; 28(2):75-83. PubMed ID: 18516986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Norbinaltorphimine, a selective kappa-opioid receptor antagonist, induces an itch-associated response in mice.
    Kamei J; Nagase H
    Eur J Pharmacol; 2001 Apr; 418(1-2):141-5. PubMed ID: 11334876
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spontaneous scratching behavior in MRL/lpr mice, a possible model for pruritus in autoimmune diseases, and antipruritic activity of a novel kappa-opioid receptor agonist nalfurafine hydrochloride.
    Umeuchi H; Kawashima Y; Aoki CA; Kurokawa T; Nakao K; Itoh M; Kikuchi K; Kato T; Okano K; Gershwin ME; Miyakawa H
    Eur J Pharmacol; 2005 Aug; 518(2-3):133-9. PubMed ID: 16055114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nalfurafine prevents 5'-guanidinonaltrindole- and compound 48/80-induced spinal c-fos expression and attenuates 5'-guanidinonaltrindole-elicited scratching behavior in mice.
    Inan S; Dun NJ; Cowan A
    Neuroscience; 2009 Sep; 163(1):23-33. PubMed ID: 19524022
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of Intrathecal κ-Opioid Receptor Agonist on Morphine-Induced Itch and Antinociception in Mice.
    Sakakihara M; Imamachi N; Saito Y
    Reg Anesth Pain Med; 2016; 41(1):69-74. PubMed ID: 26587674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blockade of mu-opioid receptor-mediated G-protein activation and antinociception by TRK-820 in mice.
    Mizoguchi H; Hung KC; Leitermann R; Narita M; Nagase H; Suzuki T; Tseng LF
    Eur J Pharmacol; 2003 Feb; 461(1):35-9. PubMed ID: 12568913
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of TRK-820, a selective kappa opioid receptor agonist, on rat schizophrenia models.
    Yoshikawa S; Hareyama N; Ikeda K; Kurokawa T; Nakajima M; Nakao K; Mochizuki H; Ichinose H
    Eur J Pharmacol; 2009 Mar; 606(1-3):102-8. PubMed ID: 19374836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory effects of TRK-820 on systemic skin scratching induced by morphine in rhesus monkeys.
    Wakasa Y; Fujiwara A; Umeuchi H; Endoh T; Okano K; Tanaka T; Nagase H
    Life Sci; 2004 Oct; 75(24):2947-57. PubMed ID: 15454345
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
    Wang Y; Tang K; Inan S; Siebert D; Holzgrabe U; Lee DY; Huang P; Li JG; Cowan A; Liu-Chen LY
    J Pharmacol Exp Ther; 2005 Jan; 312(1):220-30. PubMed ID: 15383632
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic kappa opioid receptor agonists in the treatment of chronic pruritus: a literature review.
    Phan NQ; Lotts T; Antal A; Bernhard JD; Ständer S
    Acta Derm Venereol; 2012 Sep; 92(5):555-60. PubMed ID: 22504709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antipruritic Effect of Nalbuphine, a Kappa Opioid Receptor Agonist, in Mice: A Pan Antipruritic.
    Inan S; Dun NJ; Cowan A
    Molecules; 2021 Sep; 26(18):. PubMed ID: 34576988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of atypical kappa-opioid receptor agonists on intrathecal morphine-induced itch and analgesia in primates.
    Ko MC; Husbands SM
    J Pharmacol Exp Ther; 2009 Jan; 328(1):193-200. PubMed ID: 18842704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacological properties of TRK-820 on cloned mu-, delta- and kappa-opioid receptors and nociceptin receptor.
    Seki T; Awamura S; Kimura C; Ide S; Sakano K; Minami M; Nagase H; Satoh M
    Eur J Pharmacol; 1999 Jul; 376(1-2):159-67. PubMed ID: 10440101
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of the role of βarrestin2 in kappa opioid receptor modulation in a mouse model of pruritus.
    Morgenweck J; Frankowski KJ; Prisinzano TE; Aubé J; Bohn LM
    Neuropharmacology; 2015 Dec; 99():600-9. PubMed ID: 26318102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TRK-820, a selective kappa-opioid agonist, produces potent antinociception in cynomolgus monkeys.
    Endoh T; Tajima A; Izumimoto N; Suzuki T; Saitoh A; Suzuki T; Narita M; Kamei J; Tseng LF; Mizoguchi H; Nagase H
    Jpn J Pharmacol; 2001 Mar; 85(3):282-90. PubMed ID: 11325021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro and in vivo pharmacological characterization of the main metabolites of nalfurafine hydrochloride.
    Nakao K; Togashi Y; Honda T; Momen S; Umeuchi H; Sakakibara S; Tanaka T; Okano K; Mochizuki H
    Eur J Pharmacol; 2012 Nov; 695(1-3):57-61. PubMed ID: 22981641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The novel kappa-opioid receptor agonist TRK-820 has no affect on the development of antinociceptive tolerance to morphine in mice.
    Tsuji M; Yamazaki M; Takeda H; Matsumiya T; Nagase H; Tseng LF; Narita M; Suzuki T
    Eur J Pharmacol; 2000 Apr; 394(1):91-5. PubMed ID: 10771039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.